NCT00366938View on ClinicalTrials.gov

Efficacy and Safety of Lumiracoxib in Patients With Knee Osteoarthritis (OA).

PHASE3CompletedINTERVENTIONAL
Enrollment

1,464

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

March 31, 2004

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Lumiracoxib

Trial Locations (1)

07936

Novartis Pharmaceuticals Corporation, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00366938 - Efficacy and Safety of Lumiracoxib in Patients With Knee Osteoarthritis (OA). | Biotech Hunter | Biotech Hunter